| Heading: |
|
| Question ID: |
1764218 |
| UIN: |
902694 |
| House: |
Commons |
| Date tabled: |
2025-02-05 |
| Asking Member ID: |
4623 |
| Asking Member display name: |
Tonia Antoniazzi
|
| Asking Member handle: |
ToniaAntoniazzi
|
| Asking Member Twitter reference: |
@ToniaAntoniazzi
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of access to medical cannabis on the NHS. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-02-11 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Licensed cannabis-based medicines are routinely funded by the NHS where there is clear evidence of their quality, safety and effectiveness. Two licensed cannabis-based medicines are available for prescribing on the NHS, but more research is required on un... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |